Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Sculptor Capital LP | SOC Sable Offshore Corp. | 13G/A | 4.53% | Dec 31, 2023 | 2y |
| LW CAPITAL MANAGEMENT, LLC | LFCR Lifecore Biomedical, Inc. De | 13G | 5.2% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | AKRO Akero Therapeutics, Inc. Common Stock | 13G | 6.6% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | GERN Geron Corp | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| CANNELL CAPITAL LLC | STIM Neuronetics, Inc. | 13G/A | 9.57% | Dec 31, 2023 | 2y |
| Commodore Capital LP | AMAM Ambrx Biopharma, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares | 13G | 8.41% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | VSTM Verastem, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| EMINENCE CAPITAL, LP | MANU Manchester United plc | 13G | 8.9% | Dec 31, 2023 | 2y |
| Sessa Capital Special Opportunity Fund II, L.P. | AIV Apartment Investment & Management Co | 13G/A | 0% | Dec 31, 2023 | 2y |
| QVT Financial LP | ROIV Roivant Sciences Ltd. | 13G/A | 13.97% | Dec 31, 2023 | 2y |
| Deep Track Capital, LP | TVTX Travere Therapeutics, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| BOOTHBAY FUND MANAGEMENT, LLC | CNTM ConnectM Technology Solutions, Inc. | 13G/A | 0.2% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | SPEC Spectaire Holdings, Inc. Common Stock | 13G/A | 0.86% | Dec 31, 2023 | 2y |
| Alyeska Investment Group, L.P. | UBX Unity Biotechnology, Inc. Common Stock | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| TURTLE CREEK ASSET MANAGEMENT INC. | BERY Berry Global Group, Inc. | 13G/A | 3.4% | Dec 31, 2023 | 2y |
| Mark Zuckerberg | META Meta Platforms, Inc. | 13G/A | 13.6% | Dec 31, 2023 | 2y |
| Alger Associates, Inc. 13-3017981 | FBRX Forte Biosciences, Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Smith Edgar R. III | FGBI First Guaranty Bancshares, Inc. | 13D/A | 8.52% | Dec 31, 2023 | 2y |
| Jean M. George | CYT Cyteir Therapeutics, Inc. Common Stock | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| Advent International, L.P. | CINT CI&T Inc | 13G/A | 70.4% | Dec 31, 2023 | 2y |
| Solel Partners LP | BIOX Bioceres Crop Solutions Corp. | 13G/A | 7.3% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | ESHA ESH Acquisition Corp. | 13G | 6.34% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | LSCC Lattice Semiconductor Corp | 13G | 8.9% | Dec 31, 2023 | 2y |
| Avidity Partners Management LP | KPTI Karyopharm Therapeutics Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | NRDS Nerdwallet, Inc. | 13G | 5.2% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | FLYW Flywire Corp | 13G/A | 4.2% | Dec 31, 2023 | 2y |
| Pfizer Inc | CLLS Cellectis S.A. | 13G/A | 3.89% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | CPTKW Crown PropTech Acquisitions | 13G | 9.9% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | APXI APx Acquisition Corp. I Class A Ordinary Share | 13G/A | 1.18% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | AUR Aurora Innovation, Inc. | 13G/A | 10.1% | Dec 31, 2023 | 2y |
| D. E. Shaw & Co., L.P. | HCVI Hennessy Capital Investment Corp. VI Class A Common Stock | 13G/A | 3.4% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | CDAQF Compass Digital Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| 683 Capital Management, LLC | SBNY Signature Bank | 13G/A | 1.5% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | ASRT Assertio Holdings, Inc. | 13G | 8% | Dec 31, 2023 | 2y |
| MWE Investments Limited | MWG Multi Ways Holdings Ltd | 13G | 66.75% | Dec 31, 2023 | 2y |
| Cormorant Asset Management, LP | KRRO Korro Bio, Inc. | 13G/A | 6.61% | Dec 31, 2023 | 2y |
| ADW Capital Partners, L.P. | PAR Par Technology Corp | 13G/A | 9.6% | Dec 31, 2023 | 2y |
| REDWOOD CAPITAL MANAGEMENT, LLC | APEI American Public Education Inc | 13G/A | 7.94% | Dec 31, 2023 | 2y |
| Katrina Lake | SFIX Stitch Fix, Inc. | 13G | 10% | Dec 31, 2023 | 2y |
| RedOne Investment Ltd | LBBB Lakeshore Acquisition II Corp. Ordinary Shares | 13G/A | 57.03% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | EWTX Edgewise Therapeutics, Inc. | 13G/A | 9.7% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | GNLN Greenlane Holdings, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| Woodson Capital Management, LP | NDLS NOODLES & Co | 13G/A | 0% | Dec 31, 2023 | 2y |
| MENORA MIVTACHIM HOLDINGS LTD. | NVMI Nova Ltd. | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| Lagoda Investment Management, L.P. | VNRX Volitionrx Ltd | 13G/A | 4.7% | Dec 31, 2023 | 2y |
| BROWN CAPITAL MANAGEMENT LLC | APPF Appfolio Inc | 13G/A | 7.33% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | KSS KOHLS Corp | 13G | 8.4% | Dec 31, 2023 | 2y |
| Crestview Partners II GP, L.P. | CWH Camping World Holdings, Inc. | 13G/A | 17% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | HCCI Heritage-Crystal Clean, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |